New Insulin Price Cap Could End Up Saving Payers Money in the Long Run
RxBenefits, a pharmacy benefits optimizer (PBO), analyzes how the new Insulin Price Cap, a result of the Inflation Reduction Act, may save payers money in the long run by...
How to Maintain Competitive Pharmacy Benefits Amid Rising Drug Costs
Attracting and retaining talent in today’s extremely competitive job market is critical. As the Great Resignation continues, more than 40% of U.S. workers who switched...
